Literature DB >> 16872788

Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

Iris van Oostrom1, Hanne Meijers-Heijboer, Hugo J Duivenvoorden, Annette H J T Bröcker-Vriends, Christi J van Asperen, Rolf H Sijmons, Caroline Seynaeve, Arthur R Van Gool, Jan G M Klijn, Aad Tibben.   

Abstract

OBJECTIVE: To study differences between individuals opting for genetic cancer susceptibility testing of a known familial BRCA1/2 and HNPCC related germline mutation.
METHODS: Coping, illness perceptions, experiences with cancer in relatives and family system characteristics were assessed in 271 applicants for genetic testing before test result disclosure. Hereditary cancer distress, worry and cancer risk perception were assessed before, 1 week after, and 6 months after disclosure.
RESULTS: Individuals from BRCA1/2 and HNPCC mutation families did not differ with regard to the number of experiences with cancer in relatives, grief symptoms, the course of cancer distress, worry and risk perception through time and most illness perceptions, coping responses and family characteristics. Individuals from BRCA1/2 families perceived hereditary cancer as more serious. They reported more frequently a passive coping style, cancer worry and a less open communication with their partner and children.
CONCLUSION: Besides subtle differences, psychological mechanisms may be mainly identical in individuals opting for BRCA1/2 and HNPCC susceptibility testing. PRACTICE IMPLICATIONS: Based on our findings, using a similar counseling approach for individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing is justified. In this approach, attention should be directed more to individual aspects than to the type of disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16872788     DOI: 10.1016/j.pec.2006.05.006

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  26 in total

1.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

2.  Does and should breast cancer genetic counselling include lifestyle advice?

Authors:  Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation.

Authors:  D W Hadley; S Ashida; J F Jenkins; K A Calzone; I R Kirsch; L M Koehly
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

4.  Using a family systems approach to investigate cancer risk communication within melanoma families.

Authors:  Julie N Harris; Jennifer Hay; Alan Kuniyuki; Maryam M Asgari; Nancy Press; Deborah J Bowen
Journal:  Psychooncology       Date:  2010-10       Impact factor: 3.894

5.  Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.

Authors:  M J Esplen; J Wong; M Aronson; K Butler; H Rothenmund; K Semotiuk; L Madlensky; C Way; E Dicks; J Green; S Gallinger
Journal:  Clin Genet       Date:  2014-10-28       Impact factor: 4.438

6.  An examination of the psychosocial factors influencing colorectal cancer patients' communication of colorectal cancer patient risk with their siblings.

Authors:  Catalina Lawsin; Katherine Duhamel; Steven Itzkowitz; Karen Brown; Helen Lim; Lina Jandorf
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

7.  The FAP self-concept scale (adult form).

Authors:  Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger
Journal:  Fam Cancer       Date:  2008-08-13       Impact factor: 2.375

8.  Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.

Authors:  Aisha S Sie; Judith B Prins; Liesbeth Spruijt; C Marleen Kets; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

9.  Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

Authors:  Kenneth P Tercyak; Beth N Peshkin; Tiffani A Demarco; Andrea Farkas Patenaude; Katherine A Schneider; Judy E Garber; Heiddis B Valdimarsdottir; Marc D Schwartz
Journal:  Genet Test       Date:  2007

Review 10.  Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact.

Authors:  Karin M Landsbergen; Judith B Prins; Han G Brunner; Floris W Kraaimaat; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2009-03-28       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.